Alsatinib 20 mg Tablet

Alsatinib 20 mg Tablet contains dasatinib, a targeted anticancer medicine used to treat certain types of blood cancer. Each tablet contains 20 mg of dasatinib and is taken orally as prescribed by a healthcare professional. It is used for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia in appropriate patients.

BUY NOW

Dasatinib is a tyrosine kinase inhibitor that blocks abnormal signaling pathways involved in the growth and survival of leukemia cells. By targeting proteins such as BCR-ABL, it helps slow the growth of abnormal blood cells. Treatment is selected according to the patient’s diagnosis, disease status, and response to therapy. Regular medical monitoring is important during treatment to assess response and manage possible adverse effects.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 20 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size Bottle of 60 Tablets
Manufacturer Alkem Laboratories Ltd

Product Also Known As

Alsatinib 20 mg Tablet, Dasatinib 20 mg Tablet, Alsatinib Dasatinib Tablet, Dasatinib Anticancer Tablet, Alsatinib Leukemia Treatment Tablet, Dasatinib Tyrosine Kinase Inhibitor Tablet